We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 73
Most popular |Most recent


DOJ Official Outlines Enforcement Priorities Under the Food, Drug, and Cosmetic Act

USA - December 17 2018 James Burnham, the Deputy Assistant Attorney General for the Consumer Protection Branch (“CPB”), addressed the annual Food and Drug Law Institute...


DOJ Intervenes in Medicare Advantage FCA Case Against Provider

USA - December 14 2018 On December 11, 2018, the Department of Justice announced that it has intervened in a False Claims Act suit against Sutter Health and its affiliate...

Jennifer Haney.


Court Recommends Dismissal of FCA Claims Against Pharmacy and Private Equity Fund, But Provides Insight Into When Funds May Be Held Responsible For Conduct of Portfolio Companies

USA - December 4 2018 As we previously reported, the government has intervened in a qui tam suit against a compounding pharmacy and its private equity fund owner alleging...


DOJ Announces Important Changes to Yates Memo

USA - November 30 2018 In a speech delivered on November 29, Deputy Attorney General Rod Rosenstein announced important limitations to the policies regarding individual...

James M. Cole, Paul E. Kalb.


Court Compels Medicare Advantage Plan to Comply With CID for Testimony in Diagnosis Coding Investigation

USA - November 20 2018 On November 13, 2018, a magistrate judge issued a report to the United States District Court for the Southern District of New York recommending that...

Jennifer Haney, Scott D. Stein.